The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
The Pharmaceutical Industry
Abstract
Introduction: characteristics and performance1 This chapter studies the pharmaceutical industry using the concepts of national innovation systems, where the pharmaceutical industry corresponds to a sector at a meso-economic level. The following sections present an economic characterization of this sector, the role of government as the new institutional framework and a characterization of technological capabilities of the pharmaceutical industry. It also presents the institutions that establish linkages with pharmaceutical firms and the knowledge flows that occur between them, together with a characterization of firms. Finally, this chapter concludes with a discussion of the factors that define the technological regime for the pharmaceutical sector, i.e. opportunity conditions, appropriability conditions, cumulativeness and knowledge base.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Appropriating the Returns from Industrial Research and Development
Levin, R. C., Klevorick, A. K., Nelson, R. R., Winter, S. G., Gilbert, R., & Griliches, Z. (1987) · Brookings Papers on Economic Activity · doi:10.2307/2534454 · Cited by 3,772
Cited by
The price of innovation: new estimates of drug development costs
DiMasi, J. A., Hansen, R. W., & Grabowski, H. G. (2003) · Journal of Health Economics · doi:10.1016/s0167-6296(02)00126-1 · Cited by 4,265
(2000) · Handbook of Health Economics · doi:10.1016/s1574-0064(00)80168-7 · Cited by 430
The Industrial Organization of Health-Care Markets
Gaynor, M., Ho, K., & Town, R. J. (2015) · Journal of Economic Literature · doi:10.1257/jel.53.2.235 · Cited by 349
Strategic determinants of decisions not to settle patent litigation
Somaya, D. (2003) · Strategic Management Journal · doi:10.1002/smj.281 · Cited by 347
New developments in tetracycline antibiotics: Glycylcyclines and tetracycline efflux pump inhibitors
Chopra, I. (2002) · Drug Resistance Updates · doi:10.1016/s1368-7646(02)00051-1 · Cited by 143
Metadata
- Venue
- Developing Innovation Systems
- Publisher
- Routledge
- Published
- 2013-09-05
- Pages
- 220-231
- OpenAlex
- W3122804432
- Cited by
- 196
- References
- 1
- FWCI
- 61.67
- Type
- book chapter
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Pharmaceutical Industry. https://app.cochat.ai/papers/10.4324/9780203056219-22
- The paper
- The Pharmaceutical Industry. (2013). Developing Innovation Systems. https://doi.org/10.4324/9780203056219-22
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.